Lataa...
Can the COVID-19 Pandemic Disrupt the Current Drug Development Practices?
Therapeutics and vaccines against the COVID-19 pandemic need to be developed rapidly and efficiently, given its severity. To maximize the efficiency and productivity of drug development, the world has adopted disruptive technologies and approaches in various drug development areas. Telehealth, chara...
Tallennettuna:
| Julkaisussa: | Int J Mol Sci |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8196831/ https://ncbi.nlm.nih.gov/pubmed/34064287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22115457 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|